Track XBIT and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Main
Market Cap$68.29M
Enterprise Value-$47.01M
Revenue (TTM)$867.00K
Net Income (TTM)-$45.54M
Free Cash Flow (TTM)-$40.21M
Financial Health
Cash$125.55M
Net Debt-$115.30M
Debt Ratio0.07
Debt to Equity0.07
Interest Coverage-
Valuation (TTM)
Price to Sales78.77
Price to Earnings-1.5
EV to EBITDA1.01
Price to Book0.49
Price to Free Cash Flow-1.7
Margins (TTM)
Gross Profit Margin-194.46%
EBITDA Margin-5359.86%
Operating Income Margin-6423.07%
Net Income Margin-5252.60%
Free Cash Flow Margin-4637.72%
Returns (5Y Avg)
Return on Invested Capital-19.93%
Return on Assets-19.06%
Return on Equity-16.99%
Return on Total Capital-19.93%
Return on Capital Employed-20.55%
Dividend Summary
Dividend Yield-
Annual Dividend-
Payout Ratio-
Ex Dividend Date2021-07-15
5-Year Dividend CAGR-
CAGR (5Y)
Revenue-97.04%
Diluted EPS-13.89%
Total Debt0.00%
Capital Expenditures-40.03%
Free Cash Flow1000.00%
CAGR (3Y)
Revenue-99.37%
Diluted EPS-10.88%
Total Debt0.00%
Capital Expenditures-20.95%
Free Cash Flow-99.66%
CAGR (1Y)
Revenue0.00%
Diluted EPS-18.62%
Total Debt-100.00%
Capital Expenditures-77.84%
Free Cash Flow-100.00%
$2.25$0.00|+0.00%
Last updated: Jul 21, 3:58 PM ET
52W High$3.61
52W Low$2.09
50D SMA$2.37
200D SMA$2.43
Volume104.19K
XBiotech Inc
5217 Winnebago Lane, Austin, TX, United States, 78744
IPO
2015
Employees
87
Industry
Biotechnology
Sector
Healthcare
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q4 20211-1
0
Analyst Ratings
No coverage data
No analyst ratings data available